azacitidine has been researched along with Hyperglycemia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Morton, A | 1 |
Kowluru, RA; Mohammad, G | 1 |
Kim, EM; Manzar, GS; Zavazava, N | 1 |
Benton, CB; Borthakur, G; Dara, S; Franklin, AR; Garcia-Manero, G; Jabbour, E; Kantarjian, H; Kwari, M; O'Brien, S; Pierce, SR; Ravandi, F; Rytting, M; Thomas, DA; Yang, H | 1 |
Chen, ACH; Fong, SW; Lee, YL; Ng, EHY; Wong, CCY; Yeung, WSB | 1 |
1 trial(s) available for azacitidine and Hyperglycemia
Article | Year |
---|---|
Safety and clinical activity of 5-aza-2'-deoxycytidine (decitabine) with or without Hyper-CVAD in relapsed/refractory acute lymphocytic leukaemia.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bone Marrow; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Decitabine; Dexamethasone; DNA Methylation; DNA, Neoplasm; Doxorubicin; Drug Administration Schedule; Female; Gastrointestinal Diseases; Humans; Hyperglycemia; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Salvage Therapy; Vincristine; Young Adult | 2014 |
4 other study(ies) available for azacitidine and Hyperglycemia
Article | Year |
---|---|
Azacitidine-induced hyperglycaemia.
Topics: Aged; Azacitidine; Female; Humans; Hyperglycemia; Myelodysplastic Syndromes | 2019 |
Epigenetics and Mitochondrial Stability in the Metabolic Memory Phenomenon Associated with Continued Progression of Diabetic Retinopathy.
Topics: Animals; Azacitidine; Cell Line; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Progression; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; DNA, Mitochondrial; Electroretinography; Endothelial Cells; Epigenesis, Genetic; Glucose; GTP Phosphohydrolases; Humans; Hyperglycemia; Male; Mitochondria; MutL Protein Homolog 1; Rats; Rats, Wistar; Retina; RNA, Small Interfering; Signal Transduction; Streptozocin | 2020 |
Demethylation of induced pluripotent stem cells from type 1 diabetic patients enhances differentiation into functional pancreatic β cells.
Topics: Animals; Azacitidine; Cadaver; Cell Differentiation; Cells, Cultured; Decitabine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Humans; Hyperglycemia; Induced Pluripotent Stem Cells; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mice, Knockout; Microscopy, Electron, Transmission; Organoids; Secretory Vesicles; Tissue Scaffolds; Transplantation, Heterologous; Transplantation, Heterotopic | 2017 |
Hyperglycemia impedes definitive endoderm differentiation of human embryonic stem cells by modulating histone methylation patterns.
Topics: Animals; Antigens, Differentiation; Azacitidine; beta Catenin; Cell Differentiation; Cell Line; Cell Lineage; DNA Modification Methylases; Endoderm; Enhancer of Zeste Homolog 2 Protein; Enzyme Inhibitors; Female; Gene Expression Regulation, Developmental; Glucose; Histones; Humans; Hyperglycemia; Male; Mesoderm; Methylation; Mice; Mice, Inbred ICR; Pancreas; Promoter Regions, Genetic; Signal Transduction; Wnt Proteins | 2017 |